Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Avono Health vs Ivy Rx

Avono Health
Graded #369

Lower grade

vs+8
Ivy Rx
Graded #189

Higher grade

The verdict

Ivy Rx takes it — 66.5/100 to 58.5/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +32
29
61
Dose & formulationAvono Health +11
75
64
Clinical oversightIvy Rx +2
80
82
Labs & monitoringEven
53
53
FulfillmentIvy Rx +10
71
81
Contract termsIvy Rx +8
47
55
Avono Health · left barIvy Rx · right bar

The numbers

MetricAvono HealthIvy Rx
WeighScore58.5/10066.5/100
GradeCC
Scorecard rank#369#189
Semaglutide$269/mo (compounded)$175/mo (starting dose, compounded)
Tirzepatide$349/mo (compounded)$275/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Avono Health

Graded #369 · C

Strengths

  • Transparent tiered pricing from $179/mo (microdose semaglutide injection)
  • Full compounded range — semaglutide and tirzepatide, injection and oral, microdose and standard
  • Free and discreet shipping; 24/7/365 messaging support; 100% online
  • US-licensed clinicians and pharmacies; bundle discounts at 3/6/12 months

Where it loses points

  • Medications are compounded, not FDA-approved brand-name
  • Compounding pharmacy not publicly named
  • State availability not published
  • Newer brand with limited independent review history
Ivy Rx

Graded #189 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard